olprinone has been researched along with Cancer of Liver in 2 studies
olprinone: RN refers to HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " The rate of post-hepatectomy liver failure frequency tended to be lower in the olprinone group." | 5.24 | Phase I clinical trial of olprinone in liver surgery. ( Fuji, H; Hatano, E; Iguchi, K; Ikeno, Y; Ishii, H; Kobayashi, M; Seo, S; Tanaka, S; Taura, K; Uemoto, S; Ueno, K; Yamanaka, K; Yasuchika, K; Yoh, T, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuji, H | 1 |
| Hatano, E | 2 |
| Iguchi, K | 1 |
| Yamanaka, K | 1 |
| Yoh, T | 1 |
| Ikeno, Y | 1 |
| Seo, S | 1 |
| Taura, K | 2 |
| Yasuchika, K | 1 |
| Tanaka, S | 1 |
| Ishii, H | 1 |
| Kobayashi, M | 1 |
| Ueno, K | 1 |
| Uemoto, S | 2 |
| Narita, M | 1 |
| Ikai, I | 1 |
| Miyagawa-Hayashino, A | 1 |
| Yanagida, A | 1 |
| Nagata, H | 1 |
| Asechi, H | 1 |
1 trial available for olprinone and Cancer of Liver
| Article | Year |
|---|---|
Phase I clinical trial of olprinone in liver surgery.
Topics: Aged; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatectomy; Humans; Imidazoles; Incidence; | 2017 |
1 other study available for olprinone and Cancer of Liver
| Article | Year |
|---|---|
A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Disease Models, Ani | 2009 |